NCT02602457

Brief Summary

Atrial fibrillation is the most common heart rhythm disorder. The management of atrial fibrillation is of great importance. Despite the presence of exercise intolerance, weight gain, and an associated decline in overall health and well-being in patients living with atrial fibrillation, recommended standard care does not currently include the prescription of exercise to address these significant health issues. Exercise training is a recognized form of treatment of persons with heart disease. An exercise program such as high-intensity interval training when compared to moderate-intensity continuous exercise training may provide a stronger training stimulus for exercise and clinical outcomes; may be more efficient and motivating; and, may help to improve adherence to exercise training in persistent or permanent atrial fibrillation patients. This has been shown in patients with coronary artery disease and heart failure. The primary objectives of this prospective study are to examine the impact of high-intensity interval training compared to moderate-intensity continuous exercise training in adults with persistent or permanent atrial fibrillation on exercise capacity and quality of life.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
53mo left

Started Nov 2015

Longer than P75 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Nov 2015Oct 2030

Study Start

First participant enrolled

November 1, 2015

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 11, 2015

Completed
14.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2030

Last Updated

April 26, 2022

Status Verified

April 1, 2022

Enrollment Period

14.2 years

First QC Date

November 3, 2015

Last Update Submit

April 25, 2022

Conditions

Keywords

Atrial Fibrillation

Outcome Measures

Primary Outcomes (2)

  • Change in quality of life as measured by the Short-Form 36 questionnaire

    Change in quality of life from baseline to 12 weeks as measured by the Short Form-36 questionnaire.

    baseline to 12 weeks

  • Change in exercise capacity as measured by six-minute walk test distance

    Change in exercise capacity from baseline to 12 weeks as measured by six-minute walk test distance.

    baseline to 12 weeks

Secondary Outcomes (12)

  • Change in exercise adherence measured by accelerometer

    baseline to 12 weeks

  • Change in activity status measured by the Duke Activity Status Index

    baseline to 12 weeks

  • Change in symptom burden measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation scale

    baseline to 12 weeks

  • Change in symptom frequency and severity measured using the 7-day symptom diary

    baseline to 12 weeks

  • Change in disease specific quality of life will be measured using the University of Toronto Atrial Fibrillation Severity Scale (AFSS)

    baseline to 12 weeks

  • +7 more secondary outcomes

Study Arms (2)

Moderate-intensity continuous exercise

EXPERIMENTAL

Moderate-intensity continuous exercise training

Behavioral: moderate-intensity continuous exercise training

High-Intensity Interval Training

EXPERIMENTAL

High-Intensity Interval Training

Behavioral: high-intensity interval training

Interventions

Participants will complete supervised exercise sessions. Moderate-intensity continuous exercise training will follow cardiovascular rehabilitation guidelines. Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.

Moderate-intensity continuous exercise

Participants will complete supervised exercise sessions. Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.

High-Intensity Interval Training

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persistent or permanent atrial fibrillation;
  • rate controlled with a resting ventricular rate of equal to or less than 110 bpm;
  • able to perform a symptom-limited exercise test;
  • at least 40 years of age;
  • patient agrees to sign informed consent.

You may not qualify if:

  • currently participating in routine exercise training (more than two times per week);
  • unstable angina;
  • uncontrolled diabetes mellitus;
  • diagnosed severe mitral or aortic stenosis;
  • diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction;
  • unable to provide written, informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa Heart Insititue

Ottawa, Ontario, K1Y 4W7, Canada

Location

Related Publications (1)

  • Reed JL, Terada T, Vidal-Almela S, Tulloch HE, Mistura M, Birnie DH, Wells GA, Nair GM, Hans H, Way KL, Chirico D, O'Neill CD, Pipe AL. Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial. JAMA Netw Open. 2022 Oct 3;5(10):e2239380. doi: 10.1001/jamanetworkopen.2022.39380.

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jennifer L Reed, PhD

    Ottawa Heart Institute Research Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2015

First Posted

November 11, 2015

Study Start

November 1, 2015

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

October 1, 2030

Last Updated

April 26, 2022

Record last verified: 2022-04

Locations